Lupin Ltd share price logo

Lupin Ltd

NSE: LUPIN

BSE: 500257

Large Cap

Healthcare Sector

₹2333.80

+38.70

(+1.69%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Lupin Stock Performance

as on April 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,290.10
    ₹2,336.40
    downward going graph

    1.87%

    Downside

    0.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,836.80
    ₹2,377.60
    downward going graph

    21.30%

    Downside

    1.88%

    Upside

    downward going graph

Lupin share price movements today

Previous Close
₹2,295.10
Open
₹2,301.60
Volume
12.69L
Upper Circuit
₹2,524.60
Lower Circuit
₹2,065.60
Day's Low - High
₹2,290.10 - ₹2,336.40
52 Week Low - High
₹1,836.80 - ₹2,377.60

Lupin Historical Returns

1 Month Return
-0.46 %
3 Month Return
+ 6.64 %
1 Year Return
+ 18.51 %
3 Year Return
+ 253.47 %
5 Year Return
+ 123.3 %

Lupin Fundamentals

as on April 10, 2026 at 4:01 pm IST

Market Cap

₹1,06,696.46 Cr

Return on Equity (ROE)

17.7

PE Ratio (TTM)

22.94

Return on capital employed (ROCE)

21.32

Industry PE ratio

41.11

Beta (LTM)

0.58

P/B Ratio

3.81

Dividend Yield

0.59

PEG Ratio

0.59

Quarterly Earnings Growth YOY

37.45

EPS (TTM)

72.41

Sector

Pharmaceuticals

Book Value

376.77

Technical Analysis

Bullish

View Technical Analysis

Lupin Stock Valuation

as on April 10, 2026 at 4:01 pm IST

Lupin in the last 5 years

  • Overview

  • Trends

Lowest (-6437.86x)

December 3, 2018

Today (22.94x)

April 10, 2026

Industry (41.11x)

April 10, 2026

Highest (517.33x)

December 2, 2022

LowHigh

Today’s Price to Earnings Ratio: 22.94x

Lupin Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lupin with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lupin Ltd image
Lupin Ltd
BUY1,06,696.4624.66%0.633,30622,707
Sanofi India Ltd image
Sanofi India Ltd
BUY8,041.85-11.37%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY78,373.379.49%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD92,110.6616.64%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY54,782.5014.26%0.001,4146,445
See all

Market expectation of Lupin Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

62.86%

Buy

28.57%

Hold

8.57%

Sell

Lupin Stock’s Investor Sentiment and Interest

Investment in Lupin Ltd Shares on INDmoney has dropped by -28.64% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-28.64% versus previous 30 day period

Search interest for Lupin Ltd Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Lupin Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
4,742.12
4,939.23
5,079.88
4,895.11
5,514.34
5,497.01
5,618.56
5,562.2
6,163.75
6,831.43
7,100.45
Other Income
22.83
40.4
29.37
29.25
67.78
42.29
53.71
56.95
79.04
90
114.7
Total Income
4,836.89
5,078.96
5,226.78
4,990.04
5,668.11
5,715.02
5,821.42
5,724.08
6,347.38
7,137.51
7,282.22
Expenses
3,957.77
4,120.8
4,159.47
3,963.94
4,359.36
4,332.37
4,411.81
4,345.96
4,541.1
4,706.18
5,332.24
Operating Profit
784.35
818.43
920.41
931.17
1,154.98
1,164.64
1,206.75
1,216.24
1,622.65
2,125.25
1,768.21
Operating Profit Margin %
16.54%
16.57%
18.12%
19.02%
20.95%
21.19%
21.48%
21.87%
26.33%
31.11%
24.9%
Profit Before Interest, Tax and Depreciation
879.12
958.16
1,067.31
1,026.1
1,308.75
1,382.65
1,409.61
1,378.12
1,806.28
2,431.33
1,949.98
Interest
85.67
80.64
74.01
71.29
68.01
70.87
66.89
89.1
91.76
107.59
114.98
Depreciation
234.66
247.85
257.2
457.1
247.71
256.92
271.45
393.18
298.98
316.77
312.96
Profit Before Tax
558.79
629.67
736.1
497.71
993.03
1,054.86
1,071.27
895.84
1,415.54
2,006.97
1,522.04
Tax Paid
105.46
134.35
117.4
129.49
187.49
195.38
212.41
113.46
194.08
522.14
341.53
Profit After Tax
453.33
495.32
618.7
368.22
805.54
859.48
858.86
782.38
1,221.46
1,484.83
1,180.51
Total Net profit including share of profit / Loss from associate company
453.33
495.32
618.7
368.22
805.54
859.48
858.86
782.38
1,221.46
1,484.83
1,180.51
EPS
9.94
10.76
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
Actual EPS
9.94
10.76
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
Adjusted EPS
9.94
10.76
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
Diluted EPS
9.9
10.72
13.41
7.86
17.52
18.64
18.69
16.87
26.62
32.28
25.67

Lupin Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
15,559.84
14,318.05
15,142.8
14,926.99
16,192.79
16,269.98
19,656.34
22,192.11
Other Income
153.87
431.22
617.8
137.62
142.05
73.36
120.17
195.82
Total Income
15,958.02
15,095.78
15,992.56
15,300.58
16,547.53
16,715.02
20,130.99
22,903.72
Expenses
14,120.99
12,443.82
13,772.03
12,596.08
16,118.26
14,843.54
16,200.3
17,424.59
Operating Profit
1,438.85
1,874.23
1,370.77
2,330.91
74.53
1,426.44
3,456.04
4,767.52
Operating Profit Margin %
9.25%
13.09%
9.05%
15.62%
0.46%
8.77%
17.58%
21.48%
Profit Before Interest, Tax and Depreciation
1,837.03
2,651.96
2,220.53
2,704.5
429.27
1,871.48
3,930.69
5,479.13
Interest
204.35
302.49
362.98
140.64
142.77
274.3
311.61
294.87
Depreciation
1,085.87
846.05
970.22
887.41
1,658.71
880.69
1,196.81
1,169.26
Profit Before Tax
546.81
1,503.42
887.33
1,676.45
-1,372.21
716.49
2,422.27
4,015
Tax Paid
288.46
887.94
1,157.11
448.52
137.15
268.8
486.7
708.74
Profit After Tax
258.35
615.48
-269.78
1,227.93
-1,509.36
447.69
1,935.57
3,306.26
Total Net profit including share of profit / Loss from associate company
258.35
615.48
-269.78
1,227.93
-1,509.36
447.69
1,935.57
3,306.26
EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
Actual EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
Adjusted EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
Diluted EPS
5.54
13.55
-5.97
26.72
-33.65
9.41
41.87
71.69

Lupin Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-382.39
4,113.51
1,751.19
1,665.97
1,468.84
1,821.76
367.31
1,897.24
3,648.36
2,999.94
Cash Flow from Investing Activities
-947.13
109.35
2,023.29
-2,297.12
1,780.12
-561.96
2,197.31
-1,286.77
-1,712.2
-4,171.89
Cash Flow from Financing Activities
5,836.38
433.18
-1,492.09
744.13
-890.58
-1,885.27
-1,572.32
-337.25
-2,184.21
1,731.88
Net Cash Flow
-1,314.84
2,019.25
728.97
-872.37
1,685.25
-1,303.09
87.22
273.22
-248.05
559.93

Lupin Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
47.07%
47.05%
47.04%
47.01%
46.98%
46.96%
46.95%
46.92%
46.9%
46.9%
46.89%
DII
28.98%
29.42%
29.73%
27.76%
26.78%
25.09%
24.74%
25.41%
25.56%
26.55%
25.58%
FII
0%
0%
16.11%
18.28%
19.32%
21.5%
22.04%
21.46%
21.25%
20.49%
21.49%
Government
0%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
9.63%
8.52%
7.11%
6.93%
6.92%
6.44%
6.26%
6.2%
6.28%
6.06%
6.03%
Total Outstanding Shares
45,50,80,018
45,52,21,984
45,53,26,550
45,56,78,908
45,59,15,953
45,61,43,312
45,62,34,542
45,65,65,045
45,67,16,123
45,67,57,868
45,67,98,806
Total Shareholders
3,22,678
2,89,074
2,81,542
2,80,248
2,88,537
2,79,280
2,81,988
2,83,210
2,86,604
2,80,256
2,88,931

Mutual Funds that own Lupin Stock

Check out the Mutual Funds with significant holdings in Lupin.

Lupin Corporate Actions

View detailed summary of the earnings and dividend history of Lupin.

  • Lupin Ltd Earnings Results

    Lupin Ltd’s net profit jumped 37.47% since last year same period to ₹1,175.55Cr in the Q3 2025-2026. On a quarterly growth basis, Lupin Ltd has generated -20.46% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Lupin Ltd Dividends May,2025

    In the quarter ending March 2025, Lupin Ltd has declared dividend of ₹12.00 per share on 14 May 2025 - translating a dividend yield of 0.52%.

    Read More about Dividends

Indices Featuring Lupin Stock

Check stock indices that include Lupin.

NIFTY PHARMA

₹22,164.85

0.13 (▲29.45%)

S&P BSE Dividend Stability

₹1,032.67

0.63 (▲6.48%)

BSE 200

₹11,020.66

1.36 (▲147.75%)

S&P BSE 100 ESG

₹403.22

1.26 (▲5.03%)

Nifty Midcap 50

₹16,452.40

1.27 (▲206.05%)

BSE 500

₹35,004.96

1.40 (▲482.97%)

S&P BSE 250 LargeMidCap

₹10,456.43

1.38 (▲142.10%)

S&P BSE SEN. N50

₹82,005.78

1.60 (▲1290.66%)

S&P BSE 150 MidCap

₹15,623.78

1.71 (▲263.30%)

Nifty 500

₹22,346.75

1.40 (▲309.25%)

Nifty Healthcare

₹14,194.90

0.12 (▲16.65%)

S&P BSE 400 MidSmallCap

₹11,500.68

1.68 (▲189.77%)

BSE 100

₹25,321.37

1.26 (▲315.31%)

Nifty 200

₹13,581.30

1.36 (▲181.95%)

BSE Healthcare

₹42,619.40

0.49 (▲209.78%)

Nifty LargeMidcap 250

₹15,891.80

1.46 (▲228.55%)

Nifty Midcap 100

₹57,843.95

1.52 (▲865.20%)

Nifty Midcap Sel

₹13,406.35

1.51 (▲199.05%)

Nifty Midcap 150

₹21,300.30

1.60 (▲334.80%)

Nifty MidSmallcap 400

₹19,246.65

1.60 (▲303.20%)

Insights on Lupin Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, LUPIN stock has moved up by 17.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LUPIN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 20.49% to 21.49% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 5.72K Cr → 7.28K Cr (in ₹), with an average increase of 7.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 30.9% return, outperforming this stock by 14.3%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 20.57% to 18.01% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.47K Cr → 1.17K Cr (in ₹), with an average decrease of 20.5% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.06% to 6.03% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.90% to 46.89% in Dec 2025 quarter

Lupin Stock Futures & Options Contracts

View the latest movement in Lupin Futures & Options, including strike prices, expiry dates, and percentage changes.

Lupin Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LUPIN 28 Apr ₹2400 Call
April 28, 2026
₹2400
₹23.35
3.9
20.05%
LUPIN 28 Apr ₹2300 Call
April 28, 2026
₹2300
₹69.8
12.1
20.97%
LUPIN 28 Apr ₹2320 Call
April 28, 2026
₹2320
₹58.5
11
23.16%
LUPIN 28 Apr ₹2340 Call
April 28, 2026
₹2340
₹47.15
8.65
22.47%

Lupin Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LUPIN 28 Apr Fut
April 28, 2026
-
₹2335.1
28.14
1.22%
LUPIN 26 May Fut
May 26, 2026
-
₹2350
31.99
1.38%
LUPIN 30 Jun Fut
June 30, 2026
-
₹2347.2
5.39
0.23%

About Lupin Ltd

Lupin Ltd is a global pharmaceutical company incorporated in 1968 with its headquarters in Mumbai, India. Lupin Ltd operates in several lines of business, including branded and generic formulations, biotechnology, active pharmaceutical ingredients (APIs), and animal health products.

The company's top products include a wide range of prescription and over-the-counter drugs, including antibiotics, cardiovascular medications, antidiabetics, and anti-asthmatics. Lupin Ltd also manufactures and markets a variety of branded products, including Metoject, Lupitac, and Lupizole. In addition, the company produces a number of popular generic drugs, such as Amlodipine, Montelukast, and Cetirizine.

Lupin Ltd is one of the world's leading manufacturers of APIs, with a portfolio that includes more than 200 APIs and intermediates. The company also produces a range of animal health products, such as veterinary vaccines, feed supplements, and pet care products.

Revenue: ₹7,100.45Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1,180.51Cr as on December 2025 (Q3 FY26)
Listing date: 30 Nov, 1994
Chairperson Name: M D Gupta
OrganisationLupin Ltd
IndustryPharmaceuticals
CEOM D Gupta
E-voting on sharesClick here to vote

FAQs

What is Lupin share price today?

Lupin share price today stands at ₹2333.8 as on at the close of the market. Lupin share today touched a day high of ₹2336.4 and a low of ₹2290.1.

What is the 52 week high and 52 week low range for Lupin share?

Lupin touched a 52 week high of ₹2377.6 and a 52 week low of ₹1836.8. Lupin share price today i.e. is closed at ₹2333.8, which is -1.84% down from its 52 week high and 27.06% up from its 52 week low.

What is Lupin's market capitalisation today?

Lupin market capitalisation is ₹1,06,696.46 Cr as on .

How to buy Lupin shares?

To buy Lupin shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LUPIN or Lupin Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lupin shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lupin trading volume today?

Lupin trading volume is 12.69L as on . This means that 12.69L shares of Lupin were bought and sold on the stock market during today's trading session.